Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression.
Souza-Marques B, Telles M, Leal GC, Faria-Guimarães D, Correia-Melo FS, Jesus-Nunes AP, Vieira F, Souza L, Lins-Silva D, Mello RP, Guerreiro-Costa L, Bandeira ID, Lacerda ALT, Sampaio AS, Quarantini LC. Souza-Marques B, et al. Among authors: vieira f. J Clin Psychopharmacol. 2022 Jul-Aug 01;42(4):408-412. doi: 10.1097/JCP.0000000000001571. Epub 2022 Jun 21. J Clin Psychopharmacol. 2022. PMID: 35727083 Clinical Trial.
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
Correia-Melo FS, Leal GC, Vieira F, Jesus-Nunes AP, Mello RP, Magnavita G, Caliman-Fontes AT, Echegaray MVF, Bandeira ID, Silva SS, Cavalcanti DE, Araújo-de-Freitas L, Sarin LM, Tuena MA, Nakahira C, Sampaio AS, Del-Porto JA, Turecki G, Loo C, Lacerda ALT, Quarantini LC. Correia-Melo FS, et al. Among authors: vieira f. J Affect Disord. 2020 Mar 1;264:527-534. doi: 10.1016/j.jad.2019.11.086. Epub 2019 Nov 14. J Affect Disord. 2020. PMID: 31786030 Clinical Trial.
Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Leal GC, Bandeira ID, Correia-Melo FS, Telles M, Mello RP, Vieira F, Lima CS, Jesus-Nunes AP, Guerreiro-Costa LNF, Marback RF, Caliman-Fontes AT, Marques BLS, Bezerra MLO, Dias-Neto AL, Silva SS, Sampaio AS, Sanacora G, Turecki G, Loo C, Lacerda ALT, Quarantini LC. Leal GC, et al. Among authors: vieira f. Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):577-582. doi: 10.1007/s00406-020-01110-5. Epub 2020 Feb 20. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 32078034 Clinical Trial.
Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial.
Vieira F, Correia-Melo FS, Santos-Lima C, Souza-Marques B, Leal GC, Jesus-Nunes AP, Mello RP, Caliman-Fontes AT, Bandeira ID, Marback RF, Telles M, Argolo FC, Lins-Silva DH, Echegaray MVF, Beanes G, Araújo-de-Freitas L, Silva SS, Cardoso TA, Kapczinski F, Turecki G, Lacerda ALT, Quarantini LC. Vieira F, et al. Gen Hosp Psychiatry. 2021 Jan-Feb;68:97-99. doi: 10.1016/j.genhosppsych.2020.12.011. Epub 2020 Dec 20. Gen Hosp Psychiatry. 2021. PMID: 33376001 Clinical Trial. No abstract available.
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial.
Mello RP, Echegaray MVF, Jesus-Nunes AP, Leal GC, Magnavita GM, Vieira F, Caliman-Fontes AT, Telles M, Guerreiro-Costa LNF, Souza-Marques B, Bandeira ID, Santos-Lima C, Marback RF, Correia-Melo FS, Lacerda ALT, Quarantini LC. Mello RP, et al. Among authors: vieira f. J Psychiatr Res. 2021 Jun;138:576-583. doi: 10.1016/j.jpsychires.2021.05.014. Epub 2021 May 8. J Psychiatr Res. 2021. PMID: 33991996 Clinical Trial.
Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study.
Araújo-de-Freitas L, Santos-Lima C, Mendonça-Filho E, Vieira F, França RJAF, Magnavita G, Cardoso TL, Correia-Melo FS, Leal GC, Jesus-Nunes AP, Souza-Marques B, Marback R, Teles M, Echegaray MV, Beanes G, Guerreiro-Costa LNF, Mello RP, Rabanea T, Lucchese AC, Abreu N, Lacerda ALT, Quarantini LC. Araújo-de-Freitas L, et al. Among authors: vieira f. Psychiatry Res. 2021 Sep;303:114058. doi: 10.1016/j.psychres.2021.114058. Epub 2021 Jun 7. Psychiatry Res. 2021. PMID: 34153630 Clinical Trial.
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Jesus-Nunes AP, Leal GC, Correia-Melo FS, Vieira F, Mello RP, Caliman-Fontes AT, Echegaray MVF, Marback RF, Guerreiro-Costa LNF, Souza-Marques B, Santos-Lima C, Souza LS, Bandeira ID, Kapczinski F, Lacerda ALT, Quarantini LC. Jesus-Nunes AP, et al. Among authors: vieira f. Hum Psychopharmacol. 2022 Jul;37(4):e2836. doi: 10.1002/hup.2836. Epub 2022 Feb 18. Hum Psychopharmacol. 2022. PMID: 35179810 Clinical Trial.
Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series.
Faria-Guimarães D, Vieira F, Souza-Marques B, Silva SS, Bandeira ID, Souza LS, Alves-Pereira R, Fontes M, Mello RP, Leal GC, Cardoso TA, Kapczinski F, Lacerda ALT, Sampaio AS, Quarantini LC. Faria-Guimarães D, et al. Among authors: vieira f. J Child Adolesc Psychopharmacol. 2022 Aug;32(6):366-367. doi: 10.1089/cap.2022.0013. Epub 2022 Jun 16. J Child Adolesc Psychopharmacol. 2022. PMID: 35708566 No abstract available.
737 results